Literature DB >> 17945395

Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis.

E Raineri1, L Crema, A De Silvestri, A Acquarolo, F Albertario, G Carnevale, N Latronico, N Petrosillo, C Tinelli, A Zoncada, A Pan.   

Abstract

Data regarding the efficacy of programmes to control meticillin-resistant Staphylococcus aureus (MRSA) in intensive care units (ICUs) are limited. We performed an observational 'before-and-after' study to evaluate the search-and-destroy (S&amp;D) strategy as compared with S&amp;D and isolation (SDI), to control MRSA in a general ICU. S&amp;D included active surveillance, contact precautions and treatment of carriers; in SDI, isolation or cohorting were added. Three phases were identified: period 1 (p1), 1996-1997, before the introduction of programme; period 2 (p2), 1998-2002, with S&amp;D programme; period 3 (p3), 2003-2005, with SDI in a new ICU. During the 10 years of the study we observed 3978 patients; 667, 1995 and 1316 patients in p1, p2 and p3 respectively. The numbers of MRSA-infected patients were 19 in p1, 23 in p2, and 6 in p3. The infection rate was 3.5, 1.7 and 0.7 cases per 1000 patient-days in p1, p2 and p3, respectively; a significant reduction was observed between p1 vs p2 (P=0.024) and p2 vs p3 (P=0.048), although the latter was not confirmed by a segmented regression analysis. The proportion of ICU-acquired MRSA cases was 80%, 77% and 52% during p1, p2 and p3, respectively (P=0.0001 for trend). The proportion of S. aureus isolates resistant to meticillin was 51%, 32% and 23% during p1, p2 and p3, respectively (P<0.0001 for trend). S&amp;D strategy was effective in significantly reducing MRSA infection, transmission rates and proportion of meticillin resistance in an ICU with endemic MRSA. SDI may further enhance S&amp;D efficacy.

Entities:  

Mesh:

Year:  2007        PMID: 17945395     DOI: 10.1016/j.jhin.2007.08.013

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  11 in total

1.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

2.  Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.

Authors:  J R Zahar; M Garrouste-Orgeas; A Vesin; C Schwebel; A Bonadona; F Philippart; C Ara-Somohano; B Misset; J F Timsit
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

3.  Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.

Authors:  Håkan Hanberger; Dilek Arman; Hans Gill; Vlastimil Jindrák; Smilja Kalenic; Andrea Kurcz; Monica Licker; Paul Naaber; Elizabeth A Scicluna; Václav Vanis; Sten M Walther
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

4.  The emergence of vancomycin-resistant Staphylococcus aureus in an intensive care unit in Kerman, Iran.

Authors:  Yasser Fasihi; Fereshteh Saffari; Shahla Mansouri; Davood Kalantar-Neyestanaki
Journal:  Wien Med Wochenschr       Date:  2017-04-19

5.  Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units--a 7-year campaign.

Authors:  Yhu-Chering Huang; Rey-In Lien; Lin-Hui Su; Yi-Hong Chou; Tzou-Yien Lin
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

Review 6.  Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review.

Authors:  Lennie P G Derde; Mirjam J D Dautzenberg; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

Review 7.  Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.

Authors:  A M Spagnolo; P Orlando; D Panatto; D Amicizia; F Perdelli; M L Cristina
Journal:  J Prev Med Hyg       Date:  2014-12

8.  Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy.

Authors:  Floriana Campanile; Dafne Bongiorno; Sonia Borbone; Stefania Stefani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-06-24       Impact factor: 3.944

9.  Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.

Authors:  Lennie P G Derde; Ben S Cooper; Herman Goossens; Surbhi Malhotra-Kumar; Rob J L Willems; Marek Gniadkowski; Waleria Hryniewicz; Joanna Empel; Mirjam J D Dautzenberg; Djillali Annane; Irene Aragão; Annie Chalfine; Uga Dumpis; Francisco Esteves; Helen Giamarellou; Igor Muzlovic; Giuseppe Nardi; George L Petrikkos; Viktorija Tomic; Antonio Torres Martí; Pascal Stammet; Christian Brun-Buisson; Marc J M Bonten
Journal:  Lancet Infect Dis       Date:  2013-10-23       Impact factor: 25.071

Review 10.  Prevention of hospital-acquired infections: review of non-pharmacological interventions.

Authors:  L T Curtis
Journal:  J Hosp Infect       Date:  2008-06-02       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.